GNMK News and Press, GenMark Diagnostics Inc. From 03/15/21

Can These Top Health Care Stocks Keep Up Their Momentum This Week? The health care sector continues to play a critical role in the economy. This could mean well for investors who have invested in health care stocks . Despite the pandemic placing an enormous strain on the global ...

Roche announced the acquisition of multiplex molecular diagnostics testing company GenMark Diagnostics for $24.05/share in cash. Roche is getting very competitive multiplex molecular diagnostics testing capabilities, but also meaningful opportunities to improve margins/operating lever...

Gainers: Sigma Labs (SGLB) +162%.Check-Cap (CHEK) +110%.Rubius Therapeutics (RUBY) +69%.Luokung Technology (LKCO) +43%.Shaw Communications (SJR) +38%.RumbleON (RMBL) +38%.Aeterna Zentaris (AEZS) +31%.Baosheng Media (BAOS) +30%.Intec Pharma (NTEC) +29%.GenMark Diagnostics (GNMK)...

OPKO Health (OPK) rose 4.2% after a report speculated that the company could become a target following Roche's deal for GenMark Diagnostics (GNMK) and as OPKO is pressured by an activist holder.OPKO, which is seeing some pressure from investor Sian Capital to sell its BioReference L...

Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Most valuable startupDigital payments giant Stripe (STRIP) is raising $600M in new funding at a $95B valuation, making it the most valuable startup in the ...

In a deal that will boost its diagnostics products, Roche (RHHBF) has agreed to buy GenMark Diagnostics (GNMK) for about $1.8B.The transaction is Roche's largest since the Swiss drugmaker bought Spark Therapeutics in 2019.GenMark investors will get $24.05 a share in cash, marking a 30% premiu...

Like most other manufacturers of diagnostic systems and test panels, Luminex has seen sales surge on COVID-19 pandemic demand. The new VERIGENE II platform offers improved system performance over the older generation, but menu expansion will be critical. The older ARIES platform c...

GenMark Diagnostics, Inc. (GNMK) Q4 2020 Earnings Conference Call February 25, 2021 04:30 PM ET Company Participants Leigh Salvo - Investor Relations, Gilmartin Group LLC Scott Mendel - President & Chief Executive Officer Johnny Ek - Chief Financial Officer Conference Call Participants Ch...

Gainers: [[GRPN]] +12.8%. [[IHRT]] +10.2%. [[ACIW]] +10.1%. [[NTRA]] +8.5%. [[ETSY]] +4%.Losers: [[TCDA]] -23.1%. [[MRIN]] -12.9%. [[TPIC]] -10%. [[TUSK]] -9.6%. [[GNMK]] -9.6%. For further details see: ETSY, GRPN, TPIC and GNMK among after-hours movers